Trial intelligence / Profile preview

Auricular Acupressure for Myopia Rebound

NCT07129889Not yet recruiting

Sponsor
Ningbo Eye Hospital
Start
Dec 2025
Primary completion
Jun 2027
Countries
1
01

Overview

Randomised, single-blind trial (3 arms), sponsored by Ningbo Eye Hospital. Primary endpoint: Myopia Rebound Rate at 12 months. Planned start Dec 2025; status: not yet recruiting.

Beyond the preview

Go deeper on NCT07129889.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07129889.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call